BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37783734)

  • 21. Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Kiyuna T; Kawaguchi K; Higuchi T; Oshiro H; Zhang Z; Wangsiricharoen S; Razmjooei S; Li Y; Nelson SD; Murakami T; Hiroshima Y; Matsuyama R; Bouvet M; Chawla SP; Singh SR; Endo I; Hoffman RM
    Cancer Chemother Pharmacol; 2019 May; 83(5):809-815. PubMed ID: 30758647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient-Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Miyake K; Kanaya F; Singh A; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Oct; 118(10):3367-3371. PubMed ID: 28300287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.
    Kawaguchi K; Igarashi K; Miyake K; Lwin TM; Miyake M; Kiyuna T; Hwang HK; Murakami T; Delong JC; Singh SR; Clary B; Bouvet M; Unno M; Hoffman RM
    Tissue Cell; 2018 Jun; 52():124-128. PubMed ID: 29857821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase.
    Igarashi K; Li S; Han Q; Tan Y; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Apr; 119(4):3537-3544. PubMed ID: 29143983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.
    Igarashi K; Kawaguchi K; Li S; Han Q; Tan Y; Murakami T; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM
    Cancer Lett; 2018 Mar; 417():168-173. PubMed ID: 29306021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
    Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
    In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.
    Hoffman RM; Murakami T; Kawaguchi K; Igarashi K; Tan Y; Li S; Han Q
    Methods Mol Biol; 2019; 1866():149-161. PubMed ID: 30725414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
    Murakami T; Murata T; Kawaguchi K; Kiyuna T; Igarashi K; Hwang HK; Hiroshima Y; Hozumi C; Komatsu S; Kikuchi T; Lwin TM; Delong JC; Miyake K; Zhang Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):61-65. PubMed ID: 28011474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib.
    Yamamoto J; Murata T; Tashiro Y; Higuchi T; Sugisawa N; Nishino H; Inubushi S; Sun YU; Lim H; Miyake K; Hongo A; Nomura T; Saitoh W; Moriya T; Tanino H; Hozumi C; Bouvet M; Singh SR; Endo I; Hoffman RM
    Anticancer Res; 2020 May; 40(5):2509-2514. PubMed ID: 32366395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Kawaguchi K; Murakami T; Chmielowski B; Igarashi K; Kiyuna T; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Nov; 7(44):71737-71743. PubMed ID: 27690220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model.
    Higuchi T; Miyake K; Sugisawa N; Oshiro H; Zhang Z; Razmjooei S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Chemother Pharmacol; 2019 Jun; 83(6):1075-1082. PubMed ID: 30929053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively
    Park JH; Zhao M; Oshiro H; Miyake K; Higuchi T; Reynoso J; Razmjooei S; Bouvet M; Clary B; Zhang Z; Sugisawa N; Yamamoto J; Singh SR; Hoffman RM
    Anticancer Res; 2019 Jul; 39(7):3463-3467. PubMed ID: 31262870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
    Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
    In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
    Hiroshima Y; Maawy AA; Katz MH; Fleming JB; Bouvet M; Endo I; Hoffman RM
    J Surg Oncol; 2015 Mar; 111(3):311-5. PubMed ID: 25394368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model.
    Lim HI; Yamamoto J; Han Q; Sun YU; Nishino H; Tashiro Y; Sugisawa N; Tan Y; Choi HJ; Nam SJ; Bouvet M; Hoffman RM
    In Vivo; 2020; 34(6):3163-3169. PubMed ID: 33144420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Kawaguchi K; Igarashi K; Murakami T; Zhao M; Zhang Y; Chmielowski B; Kiyuna T; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Aug; 118(8):2314-2319. PubMed ID: 28106277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
    Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.